COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect
Takis - Symbola
Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML
Italian company designs anti-omicron COVID-19 vaccine | Arab News
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect
Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate - Applied DNA Sciences
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
Home
News
Coronavirus, vaccino italiano con l'accordo Takis-Rottapharm - Il Sole 24 ORE
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV - Applied DNA Sciences
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV | Business Wire
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
Home
Full article: COVID-19 vaccine: where are we now and where should we go?
The pandemic pipeline
Home
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate - Applied DNA Sciences
Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector - Dube - 2021 - Advanced Therapeutics - Wiley Online Library
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 | bioRxiv
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed - Applied DNA Sciences
